28.04.2012
- French drugmaker Sanofi posted better-than-expected quarterly results, bolstered by strong emerging markets, breaking with a trend of earnings misses by European rivals AstraZeneca...
27.04.2012
- A European Union plan to tighten drug packaging rules in a bid to stamp out counterfeits has triggered a row between makers of big name medicines and those producing cheap generics...
26.04.2012
- Johnson & Johnson is sending in a former Army Ranger to clean up several big messes that have hurt its reputation, earnings and share price in the past three years. Alex Gorsky...
26.04.2012
- The Federal Trade Commission on Wednesday lost its latest attempt to thwart deals to delay the production of cheaper, generic drugs that brand-name drug companies make with...
25.04.2012
- U.S. biotech company Amgen is to buy Turkey's Mustafa Nevzat Pharmaceuticals, a maker of injectable generic drugs, for around $700 million in a deal underscoring Western drugmakers...
24.04.2012
- Watson Pharmaceuticals aims to announce an agreement to buy Actavis for around $6 billion on Wednesday, April 25th, in a deal making it one of the world's biggest suppliers of...
18.04.2012
- The U.S. Supreme Court ruled on Tuesday in favor of a generic drugmaker in a case over how companies can fight brand-name rivals in an effort to get their cheaper medicines to...
13.04.2012
- Europe's drugs watchdog is to evaluate a copycat version of the best-selling biotech drug Remicade, used to treat arthritis, in a move that underscores how the market for so-called...
